Manufacture of the PI3K β‑Sparing Inhibitor Taselisib. Part 2: Development of a Highly Efficient and Regioselective Late-Stage Process.

Autor: St-Jean, Frédéric, Remarchuk, Travis, Angelaud, Rémy, Carrera, Diane E., Beaudry, Danial, Malhotra, Sushant, McClory, Andrew, Kumar, Archana, Ohlenbusch, Gerd, Schuster, Andreas M., Gosselin, Francis
Zdroj: Organic Process Research & Development; May2019, Vol. 23 Issue 5, p783-793, 11p
Databáze: Supplemental Index